Tree.com (TREE) Is Attractively Priced Despite Fast-paced Momentum

The article highlights a 'Fast-Paced Momentum at a Bargain' investment strategy, identifying stocks with strong price momentum that are still attractively valued. Tree.com (TREE) is presented as a key example, demonstrating significant recent price appreciation (33% in four weeks, 44% in 12 weeks) and a high beta of 1.58, earning it a Zacks Momentum Score of A and a Zacks Rank #1 (Strong Buy). Crucially, despite its momentum, TREE trades at a low Price-to-Sales ratio of 0.73x, suggesting it offers substantial upside potential as a growth stock at a reasonable valuation.

Analysis

The provided analysis from Zacks Investment Research posits an investment thesis for Tree.com (TREE) based on a 'Fast-Paced Momentum at a Bargain' strategy. This approach identifies stocks exhibiting strong price appreciation while maintaining an attractive valuation. TREE's momentum is quantified by a 33% price increase over the past four weeks and a 44% gain over the last 12 weeks, supported by a high beta of 1.58, which indicates volatility 58% greater than the broader market. These technical factors contribute to its Zacks Momentum Score of 'A'. Concurrently, the stock is presented as undervalued based on its Price-to-Sales (P/S) ratio of 0.73x. The bullish outlook is further reinforced by fundamental signals, specifically a Zacks Rank #1 (Strong Buy), which the report attributes to an upward trend in earnings estimate revisions from covering analysts, a factor believed to attract investor interest and fuel price increases.

Key Decisions for Investors

• Investors with a higher risk tolerance could consider TREE, given its combination of strong, quantified price momentum and a low Price-to-Sales ratio of 0.73x, but should be prepared for significant volatility as indicated by its 1.58 beta.
• The investment case is heavily dependent on continued positive analyst sentiment; therefore, monitoring for any downgrades to the Zacks Rank or negative shifts in earnings estimate revisions is critical, as this could invalidate the core thesis.
• Given the stock's recent 44% run-up over 12 weeks, investors should watch the P/S valuation multiple closely, as a significant expansion from the current 0.73x level could erode the 'bargain' component of the strategy and increase downside risk.